China's Pharmaceutical Foreign Trade Surplus Reached $7.051 Billion In The First Half of Year

In the first half of year,China's medicine trade import and export reached $43.237 billion,increasing for 10.28% from a year earlier.Among them,export is $25.144 billion,increasing for 7.11% from a year earlier,import is $18.093 billion,increasing for15.01% from a year earlier,foreign trade surplus is $7.051 billion.

In the first half of the year,global economic growth was short of power,the international market demand has not been radically improved,which resulting in a decline in international medicine trade.In view of the adverse change of the situation,Chinese medicine and health products import and export chamber of commerce guides,coordinate industries and enterprises respond actively.Such as coordinating with the EU directive 62 and hs code classification problem,organizating of VC antitrust case,organizating CPhI fair and so on large-scale medical exhibition,also holding a series of key international markets and trade promotion activities,which eases import and export enterprises difficult,enhanced business confidence.

After a spurt of growth in 2011,pharmaceutical imports grew into the orbit of relatively steady growth in the nearly two years.In the first half of the year medical and health product import reached $18.093 billion,increasing for 15.01% from a year earlier.Among them,API was from a complete set of imported by the foreign drive,parts characteristics of material procurement transferred to China,growth trend continued to slow down,growth is 4.66%,accounting for 20.76%,decreasing for 2.1%.Western medicine preparations import accounted for 29.28%,increasing for10.99% from a year earlier.Medical equipment import was $4.88 billion,increasing for 11.42% from a year earlier.It is important to note that the first half of the year,Roche multinational drug companies,Abbott laboratories and other biomedical import was $1.648 billion,increasing for36.5% from a year earlier.This judgment,multinational drug companies are stepping up biomedical and diagnostic reagents in China.

Looking forward to in the second half,medicine in our country foreign trade is expected to enter a relatively long period of complex,Instability and uncertainty will increase.API exports to the European Union will through the hard time in the third quarter.Such as characteristics of active pharmaceutical ingredients,western medicine preparations,diagnosis and treatment equipment continue to maintain rapid growth,European and American market demand have difficult to be obvious difference,emerging market shares expected to continue to expand,pharmaceutical import and export throughout the year is expected to achieve a slight increase over last year.

By Grant